Canreal Injection 1's
₹10807.6*
MRP ₹13180
18% off
₹11203*
MRP ₹13180
15% CB
₹1977 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Canreal Injection 1's belongs to the group of medicines called 'antiplatelet agents' used to prevent the formation of blood clots, thereby reducing the chance of Myocardial infarction. Canreal Injection 1's is used during percutaneous coronary intervention (PCI) procedure to reduce the chance of blood clot formation.
Canreal Injection 1's contains Cangrelor, which works by inhibiting the clumping of platelets, thereby reducing the chance of blood clot formation. This results in lower cardiovascular events like myocardial infarction (heart attack), repeat coronary revascularization, and stent thrombosis (ST).
Canreal Injection 1's will be administered by your doctor. So, do not self-administer. The dose of the medicine will be decided by your doctor based on your health condition. Canreal Injection 1's may cause certain side effects such as nose bleeds, skin rash, bleeding in the bowels, blood in urine, low haemoglobin, indigestion and bruising. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor.
Canreal Injection 1's should not be used if you ever had a brain stroke, bleeding in the brain or transient ischemic attack (stroke). Talk to your doctor before receiving Canreal Injection 1's, have/had a recent severe injury or surgery due to risk of severe bleeding problems. If you are pregnant or breastfeeding, inform your doctor before receiving this medicine. Canreal Injection 1's is not recommended for children as efficacy and safety have not been established.
Canreal Injection 1's belongs to the group of medicines called antiplatelet agents (P2Y12 platelet inhibitors) used to prevent the formation of blood clots. Canreal Injection 1's helps in reducing the chance of having a myocardial infarction (heart attack), repeat coronary revascularization, and stent thrombosis (ST). Canreal Injection 1's works by inhibiting the clumping of platelets, thereby reducing the chance of blood clot formation. This helps in reducing the rate of cardiovascular events such as myocardial infarction (heart attack) or stroke, especially in people who have had heart surgery, known as angioplasty.
Do not receive Canreal Injection 1's if you are allergic to it or if you have a medical condition that causes bleeding from the stomach or intestine, had a transient ischemic attack (stroke) or if you are suffering from severe liver disease. Let your doctor know if you have bleeding problems, had/have a recent serious injury or surgery, or kidney or liver disease before receiving this medicine. Consult your doctor immediately if you develop a medical condition called thrombotic thrombocytopenic purpura (blood disorder) while on treatment with Canreal Injection 1's. Pregnant or breastfeeding mothers should inform their doctor before receiving this medicine. Canreal Injection 1's is not recommended for children as efficacy and safety have not been established. People affected with active pathological bleeding (peptic ulcer, intracranial or brain haemorrhage) and a history of stroke or transient ischemic attack (TIA) should not take Canreal Injection 1's.
Drug-Drug Interactions: Canreal Injection 1's may interact with pain killers (aspirin, ibuprofen, celecoxib, hydrocodone, tramadol), blood thinners (clopidogrel, dalteparin, enoxaparin, rivaroxaban, prasugrel), and drug used to prevent heart attack or stroke (ticagrelor).
Drug-Food Interactions: Avoid smoking and alcohol consumption.
Drug-Disease Interactions: Inform your doctor if you have bleeding problems, coronary and cerebral vascular disease, liver or kidney disease.
Blood clot: Platelets are small cell particles that circulate in the blood. When the blood vessel is damaged or cut, the platelets clump together and lead to the formation of a clot. Thus it prevents bleeding. The formation of clots in arteries can cut off the blood supply, leading to heart attack, stroke or death. Clot formation in the arteries that supply blood to the heart may cause reduced blood flow which could lead to unstable angina (chest pain).
Myocardial infarction: Myocardial infarction, also known as a heart attack or stroke, could occur due to the lack of blood and oxygen supply in the heart. Symptoms include chest pain, upper body pain, sweating, weakness, trouble breathing, lightheadedness and nausea.
Country of origin
Alcohol
Unsafe
Alcohol intake might increase the risk of stomach or intestine bleeding. Hence, avoid alcohol consumption while receiving Canreal Injection 1's to prevent unpleasant side effects.
Pregnancy
Caution
If you are pregnant or planning pregnancy, inform your doctor before receiving Canreal Injection 1's. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Breast Feeding
Caution
Limited data are available on the effect of Canreal Injection 1's on breastfeeding. Hence, if you are a nursing mother, inform your doctor before receiving Canreal Injection 1's. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Driving
Caution
Canreal Injection 1's does not affect your ability to drive. However, do not drive or operate heavy machinery if you are not alert.
Liver
Caution
Canreal Injection 1's should be used with caution in patients with liver impairment. Please consult your doctor if you have liver disease or any concerns regarding this.
Kidney
Caution
Canreal Injection 1's should be used with caution in patients with kidney impairment. Please consult your doctor if you have kidney disease or any concerns regarding this.
Children
Unsafe
Canreal Injection 1's is not recommended for use in children, as efficacy and safety have not been established.
We provide you with authentic, trustworthy and relevant information